Cathepsin K inhibition alleviates periodontal bone resorption by promoting type H vessel formation through PDGF‐BB / PDGFR ‐β axis
Oral Diseases · 2024
DOI: 10.1111/odi.14920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Huan Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Becaplermin, Cathepsin K, Receptor, Platelet-Derived Growth Factor beta, Alveolar Bone Loss. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Natural Science Fund basic research program of Shaanxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To explore the effects of cathepsin K (CTSK) inhibition on type H vessel formation and alveolar bone resorption within periodontitis.
Methods
Conditioned media derived from preosteoclasts pretreated with the CTSK inhibitor odanacatib (ODN), ODN supplemented small interfering RNA targeting PDGF‐BB (si‐PDGF‐BB), or PBS were prepared, to assess their proangiogenic effects on endothelial cells (HUVECs). A series of angiogenic‐related assays were conducted to evaluate HUVEC proliferation, migration, and tube formation abilities in vitro. In addition, qRT‐PCR and Western blot assays were employed to examine the expression levels of genes/proteins related to PDGF‐BB/PDGFR‐β axis components. A mouse periodontitis model was established to evaluate the effects of CTSK inhibition on type H vessel formation.
Results
CTSK inhibition promoted PDGF‐BB secretion from preosteoclasts and proliferation, migration, and tube formation activities of HUVECs in vitro. However, the conditioned medium from preosteoclasts pretreated by si‐PDGF‐BB impaired the angiogenic activities of HUVECs. This promoted angiogenesis function by CTSK inhibition may be mediated by the PDGF‐BB/PDGFR‐β axis. Functionally, in vivo studies demonstrated that CTSK inhibition significantly accelerated type H vessel formation and alleviated bone loss within periodontitis.
Conclusion
CTSK inhibition promotes type H vessel formation and attenuates alveolar bone resorption within periodontitis via PDGF‐BB/PDGFR‐β axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
- Department of Periodontology, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
- Department of Orthodontics, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
- Department of Pediatric Dentistry, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
ORCID-Profile: Yue Chen
Förderung
- the National Natural Science Foundation of China
- Natural Science Fund basic research program of Shaanxi Province
- National Natural Science Foundation of China
Zitieren
APA
Zhou, H., Zhang, Y. F., Zhang, Q. Q., Liu, F., Zhang, J. Y., & Chen, Y. (2024). Cathepsin K inhibition alleviates periodontal bone resorption by promoting type H vessel formation through PDGF‐BB / PDGFR ‐β axis. Oral Diseases. https://doi.org/10.1111/odi.14920
Vancouver
Zhou H, Zhang YF, Zhang QQ, Liu F, Zhang JY, Chen Y. Cathepsin K inhibition alleviates periodontal bone resorption by promoting type H vessel formation through PDGF‐BB / PDGFR ‐β axis. Oral Diseases. 2024. doi:10.1111/odi.14920
BibTeX
@article{Zhou2024,
author = {Zhou, Huan and Zhang, Yi-Fan and Zhang, Qian-Qian and Liu, Fen and Zhang, Jia-Yu and Chen, Yue},
title = {Cathepsin K inhibition alleviates periodontal bone resorption by promoting type H vessel formation through PDGF‐BB / PDGFR ‐β axis},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14920}
}
EUVIMED